Active-ingredient Dossier
Timolol
Active-ingredient Dossier for Timolol (beta blocker). Australian brands, products, PBS listings, PBAC outcomes — compiled by arcimedes.
- Brand: VIZO-PF
- Brand: APOTEX-Latanoprost/Timolol
- Brand: TIMOEYE
- Brand: TIMOPTOL-XE
- Brand: APO-TRAVOPROST/TIMOLOL
- Brand: DORZOLAMIDE/TIMOLOL
- Therapeutic area: Ophthalmology
What is
Timolol Timolol is a beta blocker.
Australian brands containing
Timolol — VIZO-PF — APOTEX-Latanoprost/Timolol — AZARGA — COSDOR — APO-TRAVOPROST/TIMOLOL — LAPROSTIM — LATANOMOL
Therapeutic areas
Timolol is registered in ophthalmology, with 7 brands containing this ingredient on the ARTG.
Sponsor landscape
Timolol is marketed by four sponsors: Arrotex Pharmaceuticals, Novartis Pharmaceuticals, Viatris, and AFT Pharmaceuticals.
PBS and regulatory activity
The latest PBAC outcome for timolol-containing products was recorded on 1 July 2022, with 2 brands having PBAC outcomes on record. No AusPARs have been recorded for timolol-containing brands.